Carbon dots with intrinsic theranostic properties for photodynamic therapy of oral squamous cell carcinoma
Source abstract
Abstract
Carbon dots (CDs) are one of the carbon-based materials with remarkable optical properties, good water dispersibility and high biocompatibility. However, few studies have emphasized the intrinsic photodynamic and anticancer properties of CDs. Herein, we used CDs as photosensitizers to explore their photodynamic therapy (PDT) effect on oral squamous cell carcinoma (OSCC) cells. The obtained CDs had an effective cellular internalization capacity and possessed good biocompatibility in both CAL-27 and UM1 cells. After irradiation, the CDs showed obvious photodynamic effects on the test cells, which were confirmed by apoptosis analysis. In addition, the CDs exhibited excellent intracellular ROS generation under irradiation, and the subsequent induced cell death may be related to a lysosome-associated pathway.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Carbon and Quantum Dots Applications · Advanced biosensing and bioanalysis techniques · Nanocluster Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Stomatology, Central Hospital Affiliated to Shandong First Medical University, Jinan, China
Department of Prosthodontics, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University & Shandong Key Laboratory of Oral Tissue Regeneration & Shandong Engineering Laboratory for Dental Materials and Oral Tissue Regeneration, Jinan, China
Funding
Natural Science Foundation of Shandong Province · Jinan Central Hospital
References (37)
Show source-provided references
1. 10.3322/caac.2129310.3322/caac.21293 ↗
2. 10.6004/jnccn.2015.010210.6004/jnccn.2015.0102 ↗
3. 10.1016/j.clindermatol.2017.06.00810.1016/j.clindermatol.2017.06.008 ↗
4. 10.1021/acsami.6b0749410.1021/acsami.6b07494 ↗
5. 10.1021/acsami.6b1650510.1021/acsami.6b16505 ↗
6. 10.1021/acsabm.0c0005010.1021/acsabm.0c00050 ↗
7. 10.1016/j.oraloncology.2017.02.01410.1016/j.oraloncology.2017.02.014 ↗
8. 10.1002/adhm.20190013210.1002/adhm.201900132 ↗
9. 10.5946/ce.2013.46.1.2410.5946/ce.2013.46.1.24 ↗
10. 10.1016/j.biopha.2018.07.04910.1016/j.biopha.2018.07.049 ↗
11. 10.1021/cr500304f10.1021/cr500304f ↗
12. 10.1039/C8MH00966J10.1039/C8MH00966J ↗
13. 10.1021/ja035557410.1021/ja0355574 ↗
14. 10.1016/j.biomaterials.2016.04.00610.1016/j.biomaterials.2016.04.006 ↗
15. 10.1038/ncomms559610.1038/ncomms5596 ↗
16. 10.1002/adma.20160141310.1002/adma.201601413 ↗
17. 10.1021/acsami.8b1531810.1021/acsami.8b15318 ↗
18. 10.1039/C4NR05712K10.1039/C4NR05712K ↗
19. 10.1002/anie.20090615410.1002/anie.200906154 ↗
20. 10.1021/ja066907010.1021/ja0669070 ↗
21. 10.1039/c1cc14860e10.1039/c1cc14860e ↗
22. 10.1021/ja040082h10.1021/ja040082h ↗
23. 10.1039/C5TB00575B10.1039/C5TB00575B ↗
24. 10.1039/C3TB21436B10.1039/C3TB21436B ↗
25. 10.1039/C6NR00247A10.1039/C6NR00247A ↗
26. 10.1111/cpr.1278610.1111/cpr.12786 ↗
27. 10.1002/adma.20120065010.1002/adma.201200650 ↗
28. 10.1021/acsami.7b1954910.1021/acsami.7b19549 ↗
29. 10.1039/C9NR01029G10.1039/C9NR01029G ↗
30. Kong T · Cel Prolif · 2019 · 53 · e1271310.1111/cpr.12713 ↗
31. 10.1002/ange.20130051910.1002/ange.201300519 ↗
32. Zhou N · RSC Adv · 2014 · 4 · 62086
33. 10.1111/cpr.1248810.1111/cpr.12488 ↗
34. 10.1007/s11051-018-4438-510.1007/s11051-018-4438-5 ↗
35. 10.1016/j.chemosphere.2020.12644010.1016/j.chemosphere.2020.126440 ↗
36. 10.1016/j.bbapap.2011.08.01610.1016/j.bbapap.2011.08.016 ↗
37. 10.1002/smll.20110000110.1002/smll.201100001 ↗